[34] Our findings indicated a more complex tumor microenvironment in the combination therapy group, as seen by increased cytokine and chemokine secretion, particularly those with enhanced anti-tumor effects, such as IL-2 and INF-γ. The gene discussed is IL2; the disease is neoplasm.